In 2017, the NSW Medical Devices Fund awarded $6.61 million to four companies to bring their innovative medical technologies to market. The Hon Brad Hazzard MP, Minister for Health, Minister for Medical Research announced the winners at NSW Parliament House on 29 August 2017.

This year’s Medical Devices Fund winners are:

SpeeDx Pty Ltd (awarded $2.5 million)

SpeeDx has commercialised the first single test worldwide which detects sexually transmitted infections and antibiotic resistance.

MedLogical Innovations (awarded $1.25 million)

ProFocal-Rx allows more than 30 per cent of prostate cancer patients to have minimally invasive therapy and preserve their prostate gland.

Baymatob Pty Ltd (awarded $1.47 million)

OliTM is a non-invasive patch capable of monitoring pregnancy and labour remotely, allowing for real-time observation.

Western Sydney Local Health District (awarded $1.39 million)

The Mu Catheter reduces hypertension by de-nerving the renal artery using a transcatheter microwave. ​​

Page Updated: Wednesday 20 September 2017